HC Advisors »

Cytokinetics shares owned by HC Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by HC Advisors from 13F filings

Historical chart of HC Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by HC Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by HC Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $271k 3.2k 83.49
2021-03-31 $210k 9.0k 23.31
2020-12-31 $617k 30k 20.78

More positions owned by HC Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Intrm Trm Tres (SCHR)
First Tr Morningstar Div Lea SHS (FDL)
Ishares Tr U.s. Tech Etf (IYW)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Wisdomtree Tr Us Smallcap Divd (DES)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr Barclays 7 10 Yr (IEF)
Apple (AAPL)
Schwab US Agg Bond ETF Us Aggregate B (SCHZ)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr U.s. Finls Etf (IYF)
Ishares Tr Us Hlthcare Etf (IYH)

View all positions for HC Advisors

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics